DBV Technologies | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Acadia Pharmaceuticals USD 123.66M 2.71M 2025-06
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
Amarin USD 36.57M 397K 2025-03
BioMarin Pharmaceutical USD 232.28M 26.16M 2025-06
DBV Technologies USD 4.31M 685K 2025-03
Halozyme Therapeutics USD 33M 9.36M 2025-06
Incyte USD 331.02M 5.33M 2025-06
Insmed USD 76.44M 71.11M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
PTC Therapeutics USD 85.26M 76.66M 2025-06
Sarepta Therapeutics USD 69.89M 63.74M 2025-06
Ultragenyx Pharmaceutical USD 86.65M 1.15M 2025-06
United Therapeutics USD 212.5M 42.4M 2025-06


DBV Technologies Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.